This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

WMD Research Center Gives The Country's Biopreparedness Effort A "D" For Medical Countermeasures Development And Availability

ANNAPOLIS, Md., Oct. 12, 2011 /PRNewswire/ -- Today the Bipartisan WMD Terrorism Research Center (WMD Center) released its "Bio-Response Report Card" stating that the United States is not adequately prepared for the threat of a bioterrorism attack despite the attempts for improvements over the past decade.

During the 10 years since the initial anthrax attacks, the government has made great progress in certain areas but has failed to meet many of the bioterrorism preparedness objectives.  The WMD Center is giving the country a "D" for the development and availability of medical countermeasures for a large-scale attack.  While the current state of preparedness is unacceptable, the WMD Center also noted that investment in countermeasures would be among the most effective use of resources.  Among other benefits, investment in countermeasures would aid in the development of a more cost effective, faster-acting second-generation anthrax vaccine better suited to treating a large-scale attack.  A second-generation anthrax vaccine has the potential to greatly improve the United States' bioterrorism preparedness, but requires additional support and attention from the federal government to accelerate development of this necessary countermeasure.

"A second generation anthrax vaccine is vital considering the warnings from the US intelligence community of the imminent threat of bioterrorism.  We are pleased that the WMD Center has worked diligently to assess the status of the medical countermeasures arsenal and outline steps for improvement," said Eric Richman, President and CEO of PharmAthene.  "The anthrax attacks of 2001 are a harsh reminder of our vulnerability to this threat and PharmAthene looks forward to working with the federal government and other organizations to develop a strategic response to future bioterrorism threats."

The WMD Center is one of many organizations analyzing the attacks of 2001 to better prepare America for the future.  Tomorrow, October 13, at 9:00 a.m., the Center for American Progress (CAP) is holding a panel discussion on this subject, which will include high-level officials who coordinated the response to the attacks in 2001.  For more information about the CAP event visit:

"I expect very compelling testimony tomorrow from these leaders who have first-hand experience responding to the threat of an anthrax attack," said Richman.  "Their concern about the current state of our nation's countermeasures should not be viewed lightly."

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $95.03 0.21%
FB $116.73 0.00%
GOOG $691.02 0.00%
TSLA $249.50 0.72%
YHOO $36.59 0.00%


Chart of I:DJI
DOW 17,830.76 -210.79 -1.17%
S&P 500 2,075.81 -19.34 -0.92%
NASDAQ 4,805.2910 -57.85 -1.19%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs